pulling all prescription and over-the-counter heartburn drugs containing ranitidine from the market on April 1, 2020. GSK ...

Zantac was originated by GSK and launched by the company in the early 1980s, which sold it as a prescription and over-the-counter (OTC) product for indications like heartburn and acid indigestion ...

The FDA banned sales of ranitidine in 2020 over possible contamination with the suspected carcinogen N-nitrosodimethylamine (NDMA. Some manufacturers of the drug voluntarily suspended sales in ...

Revenue dipped 1.7 percent to £8 billion in the reporting period, a statement added. GSK earlier this month agreed to pay $2.3 billion to end lawsuits alleging that Zantac caused cancer ...

GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...

The “.1” stands for the subwoofer, which usually has its own amplifier built in so your receiver won’t need to provide it with power. Many mid- and higher-priced receivers are labeled as ...

Orianthi, is partnering with Orange Amplification to release a travel-friendly amp that’s both functional and reliable. The ...

Tens of thousands of Americans are in line to share $2.2bn (£1.7bn) after GSK agreed a settlement ... of US lawsuits claiming its heartburn drug Zantac caused cancer. The company said it had ...

GSK plc (LSE/NYSE: GSK) today announced that it has reached agreements with 10 plaintiff firms who together represent 93% (approximately 80,000) of the Zantac ... for 2024 of £1.8 billion ...

AMP sold AMP Capital in August 2022, and since then, it has returned $1.1 billion to investors through a mixture of on-market share buybacks and dividends. Now this program is completed ...